Literature DB >> 1836454

Regulation of human hst expression by an enhancer element residing in the third exon.

A Sasaki1, M Kubo, S Hasan, Y Yano, M Kakinuma.   

Abstract

The hst gene is exclusively expressed in undifferentiated embryonal carcinoma cell lines and at a limited stage of embryonal development. Two DNase I-hypersensitive sites were mapped in the 3' region (approximately 3.5 and 4.5 kb downstream of the translational initiation site) of the human hst gene, irrespective of the presence or absence of hst mRNA in the cells. A DNA fragment containing one of these DNase I-hypersensitive sites (at around 3.5 kb relative to the translational initiation site) showed enhancer activity when tested by chloramphenicol acetyltransferase (CAT) assay. These results strongly suggest that an enhancer element(s) exists in the third exon of the hst and that the expression of the hst may be regulated by the presence or absence of a putative protein factor(s) which binds to the enhancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1836454      PMCID: PMC5918324          DOI: 10.1111/j.1349-7006.1991.tb01778.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

1.  The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors.

Authors:  X Zhan; B Bates; X G Hu; M Goldfarb
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

2.  Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma.

Authors:  J Adelaide; M G Mattei; I Marics; F Raybaud; J Planche; O De Lapeyriere; D Birnbaum
Journal:  Oncogene       Date:  1988-04       Impact factor: 9.867

3.  Genomic clone of hst with transforming activity from a patient with acute leukemia.

Authors:  T Yoshida; H Sakamoto; K Miyagawa; P F Little; M Terada; T Sugimura
Journal:  Biochem Biophys Res Commun       Date:  1987-02-13       Impact factor: 3.575

4.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

Authors:  P W Finch; J S Rubin; T Miki; D Ron; S A Aaronson
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

5.  Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells.

Authors:  A M Curatola; C Basilico
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

6.  Isolation of a rearranged human transforming gene following transfection of Kaposi sarcoma DNA.

Authors:  P Delli Bovi; C Basilico
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity.

Authors:  M Taira; T Yoshida; K Miyagawa; H Sakamoto; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein.

Authors:  T Yoshida; K Miyagawa; H Odagiri; H Sakamoto; P F Little; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

9.  An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family.

Authors:  P Delli Bovi; A M Curatola; F G Kern; A Greco; M Ittmann; C Basilico
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

10.  The mouse homologue of hst/k-FGF: sequence, genome organization and location relative to int-2.

Authors:  S Brookes; R Smith; J Thurlow; C Dickson; G Peters
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

View more
  1 in total

1.  Genome-scale identification of Caenorhabditis elegans regulatory elements by tiling-array mapping of DNase I hypersensitive sites.

Authors:  Baochen Shi; Xiangqian Guo; Tao Wu; Sitong Sheng; Jie Wang; Geir Skogerbø; Xiaopeng Zhu; Runsheng Chen
Journal:  BMC Genomics       Date:  2009-02-25       Impact factor: 3.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.